Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 11
Corrigendum
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,939 | Dovepress* | 8,716+ | 1,533 | 10,249 | |
| PubMed Central* | 223 | 83 | 306 | ||
| Totals | 8,939 | 1,616 | 10,555 | ||
| *Since 14 January 2019 | |||||
View citations on PubMed Central and Google Scholar